✦ LIBER ✦

Reversible Cardiomyopathy Associated with Multicentric Castleman Disease: Successful Treatment with Tocilizumab, an Anti—Interleukin 6 Receptor Antibody

✍ Scribed by Junya Kanda; Hiroshi Kawabata; Yuhei Yamaji; Tatsuo Ichinohe; Takayuki Ishikawa; Toshihiro Tamura; Yutaka Furukawa; Takeshi Kimura; Toru Kita; Takashi Uchiyama

Book ID: 111711395
Publisher: Carden Jennings Publishing
Year: 2007
Tongue: English
Weight: 640 KB
Volume: 85
Category: Article
ISSN: 0925-5710
DOI: 10.1532/ijh97.06186

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anti-interleukin 6 receptor antibody toc

Anti-interleukin 6 receptor antibody tocilizumab reduces the level of serum hepcidin in patients with multicentric Castleman's disease

✍ Kawabata, H.; Tomosugi, N.; Kanda, J.; Tanaka, Y.; Yoshizaki, K.; Uchiyama, T. 📂 Article 📅 2007 🏛 Ferrata Storti Foundation 🌐 Italian ⚖ 228 KB

Successful treatment of reactive arthrit

Successful treatment of reactive arthritis with a humanized antiâinterleukin-6 receptor antibody, tocilizumab

✍ Tanaka, Toshio ;Kuwahara, Yusuke ;Shima, Yoshihito ;Hirano, Toru ;Kawai, Mari ;O 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 1 views

Down-regulation of hepcidin resulting fr

Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease

✍ Song, S.-N. J.; Tomosugi, N.; Kawabata, H.; Ishikawa, T.; Nishikawa, T.; Yoshiza 📂 Article 📅 2010 🏛 American Society of Hematology 🌐 English ⚖ 306 KB

Short-term efficacy of the IL6 receptor

Short-term efficacy of the IL6 receptor antibody tocilizumab in patients with HIV-associated multicentric Castleman disease: report of two cases

✍ Nagao, Azusa; Nakazawa, Shoko; Hanabusa, Hideji 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 202 KB

Role of interleukin-6 in a patient with

Role of interleukin-6 in a patient with tumor necrosis factor receptor–associated periodic syndrome: Assessment of outcomes following treatment with the anti–interleukin-6 receptor monoclonal antibody tocilizumab

✍ Prashantha M. Vaitla; Paul M. Radford; Patrick J. Tighe; Richard J. Powell; Eliz 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

Tocilizumab: A novel humanized anti-inte

Tocilizumab: A novel humanized anti-interleukin 6 (IL-6) receptor antibody for the treatment of patients with non-RA systemic, inflammatory rheumatic diseases

✍ Alten, Rieke; Maleitzke, Tazio 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 289 KB